MINOR EFFECT OF TOLCAPONE, A CATECHOL-O-METHYLTRANSFERASE INHIBITOR, ON EXTRACELLULAR DOPAMINE LEVELS MODIFIED BY AMPHETAMINE OR PARGYLINE - A MICRODIALYSIS STUDY IN ANESTHETIZED RATS

Citation
P. Tuomainen et al., MINOR EFFECT OF TOLCAPONE, A CATECHOL-O-METHYLTRANSFERASE INHIBITOR, ON EXTRACELLULAR DOPAMINE LEVELS MODIFIED BY AMPHETAMINE OR PARGYLINE - A MICRODIALYSIS STUDY IN ANESTHETIZED RATS, Pharmacology & toxicology, 78(6), 1996, pp. 392-396
Citations number
39
Categorie Soggetti
Pharmacology & Pharmacy",Toxicology
Journal title
ISSN journal
09019928
Volume
78
Issue
6
Year of publication
1996
Pages
392 - 396
Database
ISI
SICI code
0901-9928(1996)78:6<392:MEOTAC>2.0.ZU;2-C
Abstract
In vivo microdialysis was used to examine the effects of tolcapone (30 mg/kg) on dopamine metabolism in amphetamine (5 mg/kg) and pargyline (75 mg/kg) treated rats. Amphetamine- or pargyline-induced decreases i n the extracellular dihydroxyphenyl acetic acid (DOPAC) levels were co unteracted by additional tolcapone. Tolcapone also decreased homovanil lic acid effluxes below those caused by amphetamine or pargyline. Howe ver, dopamine effluxes were not further enhanced by additional tolcapo ne. These results show that central metabolism of dopamine can be modu lated by catechol-O-methyltransferase (COMT) inhibition also without e xogenous L-DOPA. However, extracellular dopamine levels are not easily increased.